Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Barrie Chubb
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Evaluating the Burden of Poor Glycemic Control Associated With Therapeutic Inertia in Patients With Type 2 Diabetes in the UK
Journal of Medical Economics
Health Policy
Related publications
Pdb76 - Cost-Effectiveness Analysis of Empagliflozin in Comparison to Liraglutide Based on Cardiovascular Outcome Trials
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin or Exenatide in Patients With Inadequately Controlled Type 2 Diabetes on Oral Antidiabetic Drugs in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release, Dulaglutide and Liraglutide in the UK
Advances in Therapy
Medicine
Pharmacology
Ce1 - Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
54-Or: Oral Semaglutide vs. Empagliflozin Added on to Metformin Monotherapy in Uncontrolled Type 2 Diabetes: PIONEER 2
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Pdb67 - Once-Weekly Semaglutide Versus Dulaglutide for the Treatment of Patients With Type 2 Diabetes in Portugal: A Long-Term Cost-Effectiveness Analysis Based on Sustain 7
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
983-P: Effect and Safety of Flexible Dose Adjustment With Oral Semaglutide vs. Sitagliptin in Type 2 Diabetes: PIONEER 7
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Dapagliflozin (Forxiga®) Versus Glipizide as Add-On Therapies in Type 2 Diabetes Mellitus (T2dm); An Update of the Cost-Effectiveness Based on Long-Term Clinical Evidence From Uk NHS Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Long-Term Clinical and Cost-Effectiveness of Collaborative Care (Versus Usual Care) for People With Mental–physical Multimorbidity: Cluster-Randomised Trial
British Journal of Psychiatry
Medicine
Psychiatry
Mental Health
